Skip to main content

4579 · RaQualia Pharma Inc. · Financials

667 JPY -12 (-1.77%) At close · Nov 12
Market Cap
17.36B JPY
Shares
26.03M
Volume · Nov 12 259.6K Avg daily vol (3M) 170.78K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Net Income
273.12M +155.2%
FY2025 Net Income FY2021–FY2025
Operating Cash Flow
-354.43M -295.9%
FY2025 Operating Cash Flow FY2021–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2025 FY2024 FY2023 FY2022 FY2021
JPY 483.72M -213.38M -337.37M 866.24M 707.86M
JPY 437.95M -357.73M -294.05M 851.01M 880.58M
JPY 164.83M 137.3M 29.61M 127.62M 124.79M
JPY 273.12M -495.03M -323.66M 723.39M 755.79M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.